Modern Chinese Medicine Group Co., Ltd.
HKEX:1643.HK
0.44 (HKD) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Revenue
| 344.075 | 399.656 | 360.695 | 308.692 | 218.767 | 173.512 | 106.466 |
| Cost of Revenue
| 239.9 | 228.87 | 202.267 | 171.831 | 119.698 | 99.855 | 62.039 |
| Gross Profit
| 104.175 | 170.786 | 158.428 | 136.861 | 99.069 | 73.657 | 44.427 |
| Gross Profit Ratio
| 0.303 | 0.427 | 0.439 | 0.443 | 0.453 | 0.425 | 0.417 |
| Reseach & Development Expenses
| 1.5 | 3 | 10.5 | 10.2 | 8.3 | 0 | 0 |
| General & Administrative Expenses
| 11.43 | 16.259 | 22.912 | 36.19 | 12.696 | 0.239 | 0.238 |
| Selling & Marketing Expenses
| 24.378 | 25.432 | 21.877 | 10.349 | 8.105 | 4.938 | 4.27 |
| SG&A
| 35.808 | 41.691 | 44.789 | 46.539 | 20.801 | 5.177 | 4.508 |
| Other Expenses
| 0.272 | 0.419 | 0.2 | 0.267 | 0.026 | 0 | 0.085 |
| Operating Expenses
| 35.808 | 41.629 | 44.789 | 46.539 | 33.987 | 9.28 | 8.918 |
| Operating Income
| 68.367 | 124.338 | 114.296 | 90.725 | 65.255 | 64.507 | 35.847 |
| Operating Income Ratio
| 0.199 | 0.311 | 0.317 | 0.294 | 0.298 | 0.372 | 0.337 |
| Total Other Income Expenses Net
| -0.061 | -0.014 | -0.074 | -0.247 | 0.001 | 0.77 | -1.077 |
| Income Before Tax
| 68.306 | 124.324 | 114.222 | 90.478 | 65.256 | 64.507 | 34.77 |
| Income Before Tax Ratio
| 0.199 | 0.311 | 0.317 | 0.293 | 0.298 | 0.372 | 0.327 |
| Income Tax Expense
| 19.511 | 36.495 | 32.446 | 26.901 | 19.019 | 16.27 | 8.889 |
| Net Income
| 48.795 | 87.829 | 81.776 | 63.577 | 46.237 | 48.237 | 25.881 |
| Net Income Ratio
| 0.142 | 0.22 | 0.227 | 0.206 | 0.211 | 0.278 | 0.243 |
| EPS
| 0.081 | 0.15 | 0.14 | 0.11 | 0.077 | 0.08 | 0.043 |
| EPS Diluted
| 0.081 | 0.15 | 0.14 | 0.11 | 0.077 | 0.08 | 0.043 |
| EBITDA
| 74.751 | 130.029 | 117.019 | 92.56 | 66.805 | 66.223 | 37.649 |
| EBITDA Ratio
| 0.217 | 0.325 | 0.324 | 0.3 | 0.305 | 0.382 | 0.354 |